Webinar – Azacitidine-Venetoclax: latest clinical updates
The NAMLG’s Educational Working Group is hosting a webinar on September 24, 2024, from 15:00 to 16:30 CEST. The webinar will provide the latest insights on using Aza-Ven in AML treatment including discussions from a Nordic perspective. Topics will include its application as a first-line treatment, dosing optimizations, and strategies for maintenance therapy.
You can find the program and zoomlink here.
There is no registration required as the webinar will be sent via Zoom, see the program for details and passcode.
The webinar is supported by AbbVie and the KG Jebsen Centre for Myeloid Blood Cancer at the University of Bergen.
